- WKN: A0LR93
- ISIN: DE000A0LR936
- Land: Deutschland
Nachricht vom 13.10.2021 | 20:20
STEICO SE: New records for revenues, earnings and profitability
DGAP-News: STEICO SE
/ Key word(s): 9 Month figures
New records for revenues, earnings and profitability
Feldkirchen (Munich), 13. October 2021 - The STEICO Group (ISIN DE000A0LR936) published its interim report on Q3 2021 today.
The high demand for ecological STEICO insulation materials and construction products is continuing and has led to new record-breaking revenues and earnings.
9-month revenues were up 27.0 % year-on-year at € 288.6 million. EBIT in the first nine months rose by 104.9 % to € 50.1 million, while net income for the first nine months lifted by 109.6% to € 35.2 million.
We are particularly pleased that we were also able to improve profitability even further. During the third quarter we recorded a new record-breaking EBIT margin of 18.2 % and the 9-month EBIT margin also reached a new record at 17.3 %.
Isolated view of the third quarter 2021
In the third quarter of 2021, the STEICO Group was able to lift its revenues in total by 22.6% to € 101.8 million (previous year: € 80.0 million) - the highest revenues ever recorded in a single quarter.
New historic highs were recorded once again for both earnings and margins.
Gross profits in Q3 totalled € 49.0 million and were thus up by 25.4% (Q3 2020: € 39.1 million).
EBITDA in Q3 totalled € 24.1 million and was thus 35.3% higher than in the previous year (Q3 2020: € 17.8 million). The EBITDA margin in the third quarter amounted to 23.1%.
EBIT in Q3 totalled € 19.0 million, up 54.9% (Q3 2020: € 12.3 million). The EBIT margin in the third quarter amounted to 18.2%.
EBT in Q3 totalled € 18.7 million, up 56.9% (Q3 2020: € 11.9 million).
Net income in Q3 totalled € 14.1 million and was thus up by 51.7% (Q3 2020: € 9.3 million).
As a result of the high level of demand, the Executive Board believes that 2022 will also be a very positive year. The capacity expansions already put in place and upcoming mean that STEICO is excellently equipped to continue its growth. If the recent dynamic growth in costs for materials and electricity does not continue, the company's management also believes that profitability will continue to be stable at a high level.
The complete report can be downloaded at: www.steico.com/en/investor-relations/investors-information
STEICO develops, produces and markets ecological construction products made of renewable raw materials. STEICO is the global market leader for wood fiber insulation materials.
STEICO is positioned as a system provider for ecological residential construction and is the only manufacturer in the industry to offer an integrated wooden construction system in which innovative wooden construction components and ecological insulation material supplement each other.
Laminated veneer lumber and I-joists form the structural components of the system. The insulation materials include flexible and stable wood fiber insulation panels, facade insulation materials, as well as cavity wall insulation made of wood fibers and cellulose. Sealing products for the building shell complete the overall system.
The STEICO Group offers its customers a unique range of products through to the prefabrication of complete components for timber element construction.
The Munich-based company's products are used in new construction and when renovating roofs, walls, ceilings, floors and facades. STEICO's products allow the construction of future-proof, healthy buildings with a particularly high quality of living and a healthy atmosphere. STEICO's products offer reliable protection against cold, heat and also noise, and they permanently improve the building's energy efficiency.
|Phone:||+49 - (0)89 - 99 15 51 - 0|
|Fax:||+49 - (0)89 - 99 15 51 - 700|
|Listed:||Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Hamburg, Munich (m:access), Stuttgart, Tradegate Exchange|
|EQS News ID:||1240620|
|End of News||DGAP News Service|
STEICO SE: New records for revenues, earnings ...
STEICO SE: Construction progress at the Gromad ...
STEICO SE: H1 2021: Revenues up by around 30%. ...
STEICO SE: Sales soar in first quarter. EBIT m ...
STEICO SE: Investment in production facilities ...
GBC im Fokus
IGEA Pharma N.V. Realignment to CBD extraction
The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.
Der AKTIONÄR News
30. November 13:30 Drei Aktien mit Abstauberlimit
30. November 13:51 CD Projekt: Sprudelnde Gewinne im Jahr nach Cyberpunk? Fehlanzeige!
30. November 13:59 JinkoSolar: Zahlen sind da – Aktie knickt ein
30. November 14:10 Podcast: Bitcoin – Utopie oder Chance im Metaverse-Zeitalter?
30. November 14:13 Opening Bell: Dow Jones mit dreistelligem Minus erwartet; Moderna, ...
News im Fokus
Vonovia SE: Vorstandsmitglieder von Vonovia werden ihre Bezugsrechte ausüben
30. November 2021, 16:02
Capital Markets Day
08. Dezember 2021
Original-Research: clearvise AG (von First Berlin Equity Research GmbH): Buy
30. November 2021